Free Trial
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Spectral Diagnostics Inc. stock logo
EDTXF
Spectral Diagnostics
$0.80
$0.91
$0.65
▼
$1.15
$235.71M0.1412,103 shs34,800 shs
Electromed, Inc. stock logo
ELMD
Electromed
$27.84
+0.1%		$32.68
$23.01
▼
$47.40
$230.59M0.478,736 shs31,169 shs
Myomo, Inc. stock logo
MYO
Myomo
$1.45
+2.5%		$1.47
$0.61
▼
$1.89
$57.24M1.58569,322 shs72,609 shs
Profound Medical stock logo
PROF
Profound Medical
$6.92
+0.1%		$6.58
$4.80
▼
$8.95
$252.83M0.75166,386 shs332,572 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Spectral Diagnostics Inc. stock logo
EDTXF
Spectral Diagnostics
+2.81%-0.99%-13.04%-18.05%-20.79%
Electromed, Inc. stock logo
ELMD
Electromed
-1.42%-2.46%+1.05%-39.10%+10.67%
Myomo, Inc. stock logo
MYO
Myomo
-2.76%-12.42%+5.22%+28.18%+19.49%
Profound Medical stock logo
PROF
Profound Medical
+21.65%+18.12%+1.47%-1.85%+2.52%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Spectral Diagnostics Inc. stock logo
EDTXF
Spectral Diagnostics
$0.80
$0.91
$0.65
▼
$1.15
$235.71M0.1412,103 shs34,800 shs
Electromed, Inc. stock logo
ELMD
Electromed
$27.84
+0.1%		$32.68
$23.01
▼
$47.40
$230.59M0.478,736 shs31,169 shs
Myomo, Inc. stock logo
MYO
Myomo
$1.45
+2.5%		$1.47
$0.61
▼
$1.89
$57.24M1.58569,322 shs72,609 shs
Profound Medical stock logo
PROF
Profound Medical
$6.92
+0.1%		$6.58
$4.80
▼
$8.95
$252.83M0.75166,386 shs332,572 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Spectral Diagnostics Inc. stock logo
EDTXF
Spectral Diagnostics
+2.81%-0.99%-13.04%-18.05%-20.79%
Electromed, Inc. stock logo
ELMD
Electromed
-1.42%-2.46%+1.05%-39.10%+10.67%
Myomo, Inc. stock logo
MYO
Myomo
-2.76%-12.42%+5.22%+28.18%+19.49%
Profound Medical stock logo
PROF
Profound Medical
+21.65%+18.12%+1.47%-1.85%+2.52%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Spectral Diagnostics Inc. stock logo
EDTXF
Spectral Diagnostics
0.00
N/AN/AN/A
Electromed, Inc. stock logo
ELMD
Electromed
2.75
Moderate Buy$43.7557.15% Upside
Myomo, Inc. stock logo
MYO
Myomo
3.00
Buy$10.00592.04% Upside
Profound Medical stock logo
PROF
Profound Medical
2.67
Moderate Buy$11.5066.18% Upside

Current Analyst Ratings Breakdown

Latest MYO, EDTXF, ELMD, and PROF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/26/2026
Electromed, Inc. stock logo
ELMD
Electromed
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$50.00
8/26/2026
Electromed, Inc. stock logo
ELMD
Electromed
Lake Street Capital logo
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$36.00 ➝ $47.00
8/12/2026
Profound Medical stock logo
PROF
Profound Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
7/29/2026
Profound Medical stock logo
PROF
Profound Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
7/27/2026
Profound Medical stock logo
PROF
Profound Medical
Raymond James Financial, Inc. logo
Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeOutperform ➝ Strong-Buy$11.00
7/14/2026
Profound Medical stock logo
PROF
Profound Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
7/13/2026
Electromed, Inc. stock logo
ELMD
Electromed
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
(Data available from 10/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Spectral Diagnostics Inc. stock logo
EDTXF
Spectral Diagnostics
$1.75M134.69N/AN/A($0.17) per share-4.71
Electromed, Inc. stock logo
ELMD
Electromed
$73.78M3.13$0.67 per share41.36$5.10 per share5.46
Myomo, Inc. stock logo
MYO
Myomo
$40.93M1.40N/AN/A$0.30 per share4.82
Profound Medical stock logo
PROF
Profound Medical
$19.09M13.26N/AN/A$1.83 per share3.78
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Spectral Diagnostics Inc. stock logo
EDTXF
Spectral Diagnostics
-$34.13M-$0.10N/AN/AN/A-1,393.13%N/A-652.72%11/6/2026 (Estimated)
Electromed, Inc. stock logo
ELMD
Electromed
$5.15M$1.3137.10N/AN/A11.34%15.71%13.37%N/A
Myomo, Inc. stock logo
MYO
Myomo
-$15.57M-$0.23N/AN/AN/A-33.53%-138.85%-39.18%11/9/2026 (Estimated)
Profound Medical stock logo
PROF
Profound Medical
-$42.57M-$0.98N/AN/AN/A-171.57%-63.03%-51.24%11/5/2026 (Estimated)

Latest MYO, EDTXF, ELMD, and PROF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/6/2026N/A
Spectral Diagnostics Inc. stock logo
EDTXF
Spectral Diagnostics
-$0.0070N/AN/AN/A$0.42 millionN/A
11/5/2026Q3 2026
Profound Medical stock logo
PROF
Profound Medical
-$0.23N/AN/AN/A$6.85 millionN/A
8/6/2026Q2 2026
Profound Medical stock logo
PROF
Profound Medical
-$0.22-$0.26-$0.04$0.26$4.75 million$2.48 million
8/5/2026Q2 2026
Myomo, Inc. stock logo
MYO
Myomo
-$0.0980-$0.09+$0.0080-$0.09$10.35 million$11.70 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Spectral Diagnostics Inc. stock logo
EDTXF
Spectral Diagnostics
N/AN/AN/AN/AN/A
Electromed, Inc. stock logo
ELMD
Electromed
N/AN/AN/AN/AN/A
Myomo, Inc. stock logo
MYO
Myomo
N/AN/AN/AN/AN/A
Profound Medical stock logo
PROF
Profound Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Spectral Diagnostics Inc. stock logo
EDTXF
Spectral Diagnostics
N/A
0.04
0.03
Electromed, Inc. stock logo
ELMD
Electromed
N/A
5.10
4.74
Myomo, Inc. stock logo
MYO
Myomo
1.98
2.31
2.01
Profound Medical stock logo
PROF
Profound Medical
N/A
6.46
5.31

Institutional Ownership

CompanyInstitutional Ownership
Spectral Diagnostics Inc. stock logo
EDTXF
Spectral Diagnostics
N/A
Electromed, Inc. stock logo
ELMD
Electromed
40.82%
Myomo, Inc. stock logo
MYO
Myomo
44.99%
Profound Medical stock logo
PROF
Profound Medical
47.86%

Insider Ownership

CompanyInsider Ownership
Spectral Diagnostics Inc. stock logo
EDTXF
Spectral Diagnostics
1.50%
Electromed, Inc. stock logo
ELMD
Electromed
11.00%
Myomo, Inc. stock logo
MYO
Myomo
12.14%
Profound Medical stock logo
PROF
Profound Medical
1.52%
CompanyEmployeesShares OutstandingFree FloatOptionable
Spectral Diagnostics Inc. stock logo
EDTXF
Spectral Diagnostics
29294.64 million290.22 millionNot Optionable
Electromed, Inc. stock logo
ELMD
Electromed
1978.29 million7.36 millionOptionable
Myomo, Inc. stock logo
MYO
Myomo
19539.61 million34.80 millionNot Optionable
Profound Medical stock logo
PROF
Profound Medical
16236.56 million36.01 millionOptionable

Recent News About These Companies

Profound Medical, Telix Pharma Sign Co-Education Deal To Advance PSMA-Informed Prostate Care
October 9 at 9:48 AM  |  rttnews.comhttps://www.rttnews.com/3697885/profound-medical-telix-pharma-sign-co-education-deal-to-advance-psma-informed-prostate-care.aspx
Profound Medical, Telix Pharmaceuticals Enter Prostate-Care Education Agreement
October 9 at 9:48 AM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/profound-medical-telix-pharmaceuticals-enter-123559328.html
Profound Medical and Telix Pharmaceuticals partner to advance prostate cancer imaging and treatment education
October 9 at 9:48 AM  |  msn.comhttps://www.msn.com/en-us/news/other/profound-medical-and-telix-pharmaceuticals-partner-to-advance-prostate-cancer-imaging-and-treatment-education/ar-AA2dU4Me
Profound Medical: Q3 Revenue Beats Outlook (Rating Upgrade)
October 9 at 8:51 AM  |  seekingalpha.comhttps://seekingalpha.com/article/4952973-profound-medical-q3-revenue-beats-outlook-rating-upgrade?utm_source=marketbeat.com&utm_medium=referral&feed_item_type=article?source=MarketBeat
Strength Seen in Profound Medical (PROF): Can Its 21.7% Jump Turn into More Strength?
October 9 at 8:45 AM  |  zacks.comhttps://www.zacks.com/stock/news/3003496/strength-seen-in-profound-medical-prof-can-its-21-7-jump-turn-into-more-strength?cid=cs-stocknewsapi-ft-fundamental_analysis|daily_price_change_5%-3003496
Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care
October 9 at 8:10 AM  |  financialpost.comF
Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care
October 9 at 7:45 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/09/3378032/33471/en/profound-medical-and-telix-pharmaceuticals-enter-co-education-agreement-to-advance-psma-informed-prostate-care.html
Profound Medical Shares Rise on 3Q Revenue Forecast Above Wall Street Estimates
October 8 at 11:56 PM  |  marketwatch.comhttps://www.marketwatch.com/story/profound-medical-shares-rise-on-3q-revenue-forecast-above-wall-street-estimates-94e95493
Profound Medical raises Q3 2026 revenue outlook above estimates
October 8 at 8:54 AM  |  streetinsider.comhttps://www.streetinsider.com/Corporate+News/Profound+Medical+raises+Q3+2026+revenue+outlook+above+estimates/27161467.html
Profound Medical Reports Strong Preliminary Third Quarter 2026 Revenue
October 7 at 4:30 PM  |  financialpost.comF
Profound Medical Reports Strong Preliminary Third Quarter 2026 Revenue
October 7 at 4:15 PM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/07/3376851/33471/en/profound-medical-reports-strong-preliminary-third-quarter-2026-revenue.html
Contrasting Utah Medical Products (NASDAQ:UTMD) & Profound Medical (NASDAQ:PROF)
October 4, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31083844
Financial Survey: Profound Medical (NASDAQ:PROF) versus Tenon Medical (NASDAQ:TNON)
September 30, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31068243
Why Profound Medical Corp.’s (PROF) Stock Is Up 5.03%
September 21, 2026  |  aaii.comA
Profound Medical (NASDAQ:PROF) Downgraded to "Sell" Rating by Wall Street Zen
September 12, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-profound-medical-nasdaq-prof-downgraded-to-sell-rating-by-wall-street-zen-2026-09-12/
Profound Medical Stock And 2 Canadian AI Healthcare Stocks To Watch
September 6, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/profound-medical-stock-2-canadian-021452828.html
Profound Medical to Participate in Lake Street’s 10th Annual Best Ideas Growth Conference
September 3, 2026  |  financialpost.comF
Profound Medical to Participate in Lake Street's 10th Annual Best Ideas Growth Conference
September 3, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/03/3355888/33471/en/profound-medical-to-participate-in-lake-street-s-10th-annual-best-ideas-growth-conference.html
Profound Medical Appoints Richard Fabian President
September 2, 2026  |  marketscreener.comM
Profound Medical Further Strengthens Executive Leadership Team with Appointment of Richard Fabian as President
September 1, 2026  |  financialpost.comF
Profound Medical Further Strengthens Executive Leadership Team with Appointment of Richard Fabian as President
September 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/01/3354103/33471/en/profound-medical-further-strengthens-executive-leadership-team-with-appointment-of-richard-fabian-as-president.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Spectral Diagnostics stock logo

Spectral Diagnostics OTCMKTS:EDTXF

$0.80 0.00 (0.00%)
As of 10/8/2026 12:07 PM Eastern

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

Electromed stock logo

Electromed NYSE:ELMD

$27.84 +0.04 (+0.14%)
As of 03:10 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Myomo stock logo

Myomo NYSEAMERICAN:MYO

$1.44 +0.04 (+2.48%)
As of 03:09 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Profound Medical stock logo

Profound Medical NASDAQ:PROF

$6.92 +0.01 (+0.14%)
As of 03:10 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas